Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO, Blickagången 16, Huddinge, 141 52, Stockholm, Sweden.
Theme Aging, Karolinska University Hospital, Stockholm, Sweden.
J Nephrol. 2021 Apr;34(2):295-304. doi: 10.1007/s40620-021-01022-0. Epub 2021 Mar 22.
Research regarding COVID-19 and acute kidney injury (AKI) in older adults is scarce. We evaluated risk factors and outcomes of AKI in hospitalized older adults with and without COVID-19.
Observational study of patients admitted to two geriatric clinics in Stockholm from March 1st to June 15th, 2020. The difference in incidence, risk factors and adverse outcomes for AKI between patients with or without COVID-19 were examined. Odds ratios (OR) for the risk of AKI and in-hospital death were obtained from logistic regression.
Three hundred-sixteen older patients were hospitalized for COVID-19 and 876 patients for non-COVID-19 diagnoses. AKI occurred in 92 (29%) patients with COVID-19 vs. 159 (18%) without COVID-19. The odds for developing AKI were higher in patients with COVID-19 (adjusted OR, 1.70; 95% confidence interval [CI] 1.04-2.76), low baseline kidney function as depicted by estimated glomerular filtration rate (eGFR) [4.19 (2.48-7.05), for eGFR 30 to < 60 mL/min, and 20.3 (9.95-41.3) for eGFR < 30 mL/min], and higher C reactive protein (CRP) (OR 1.81 (1.11-2.95) in patients with initial CRP > 10 mg/L). Compared to patients without COVID-19 and without AKI, the risk of in-hospital death was highest in patients with COVID-19 and AKI [OR 80.3, 95% CI (27.3-235.6)], followed by COVID-19 without AKI [16.3 (6.28-42.4)], and by patients without COVID-19 and with AKI [10.2 (3.66-28.2)].
Geriatric patients hospitalized with COVID-19 had a higher incidence of AKI compared to patients hospitalized for other diagnoses. COVID-19 and reduced baseline kidney function were risk factors for developing AKI. AKI and COVID-19 were associated with in-hospital death.
关于 COVID-19 和老年人急性肾损伤 (AKI) 的研究很少。我们评估了住院老年 COVID-19 患者和非 COVID-19 患者 AKI 的危险因素和结局。
这是一项观察性研究,纳入 2020 年 3 月 1 日至 6 月 15 日在斯德哥尔摩两家老年诊所住院的患者。比较 COVID-19 患者和非 COVID-19 患者 AKI 的发生率、危险因素和不良结局。通过逻辑回归获得 AKI 和住院死亡的风险比 (OR)。
316 例老年患者因 COVID-19 住院,876 例因非 COVID-19 诊断住院。COVID-19 患者中发生 AKI 的有 92 例 (29%),而非 COVID-19 患者中发生 AKI 的有 159 例 (18%)。COVID-19 患者发生 AKI 的几率更高 (调整后的 OR,1.70;95%置信区间 [CI] 1.04-2.76),肾小球滤过率 (eGFR) 较低(定义为 eGFR 30 至 < 60 mL/min,4.19 [2.48-7.05];eGFR < 30 mL/min,20.3 [9.95-41.3]),C 反应蛋白 (CRP) 较高 (初始 CRP>10 mg/L 时,OR 1.81 [1.11-2.95])。与非 COVID-19 且无 AKI 的患者相比,COVID-19 且 AKI 的患者住院期间死亡风险最高[OR 80.3,95%CI (27.3-235.6)],其次是 COVID-19 但无 AKI [16.3 (6.28-42.4)],再次是无 COVID-19 但有 AKI [10.2 (3.66-28.2)]。
与因其他诊断住院的患者相比,因 COVID-19 住院的老年患者 AKI 发生率更高。COVID-19 和基础肾功能降低是发生 AKI 的危险因素。AKI 和 COVID-19 与住院期间死亡相关。